Autophagy Induced by Naftopidil Inhibits Apoptosis of Human Gastric Cancer Cells

被引:4
作者
Nakamura, Azumi [1 ,2 ]
Matsunaga, Wataru [1 ]
Gotoh, Akinobu [1 ]
机构
[1] Hyogo Coll Med, Inst Adv Med Sci, Lab Cell & Gene Therapy, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan
[2] Kwansei Gakuin Univ, Grad Sch Sci & Technol, Dept Bioschience, Sanda, Japan
关键词
Naftopidil; drug repositioning; apoptosis; autophagy; gastric cancer; ALPHA(1)-ADRENOCEPTOR ANTAGONIST; ALPHA-1-ADRENOCEPTOR ANTAGONIST; HUMAN BLADDER; PROSTATE; GROWTH;
D O I
10.21873/anticanres.12287
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: Naftopidil is used to treat benign prostate hyperplasia. Moreover, previous studies have shown that naftopidil reduced viability of many types of cancer cells. Therefore, we investigated the antitumor mechanism of naftopidil in this study. Materials and Methods: We used the HGC27 human gastric cancer cell line. It was treated with naftopidil, pan-caspase inhibitor, and chloroquine diphosphate (CQ). Cell viability and cell death were investigated by the assay and annexin V/propidium iodide assay. Phosphorylation of protein kinase B (AKT) (Ser473) was measured by western blotting. Alteration of light chain 3B (LC3B) was investigated by western blotting and immunofluorescence. Results: Naftopidil reduced phospho-AKT (Ser473) and altered LC3B. Combination of naftopidil and CQ reduced cell viability and phospho-AKT (Ser 473). Conclusion: Naftopidil induces apoptosis and autophagy of HGC27 cells, however, autophagy is considered to inhibit apoptosis. We concluded naftopidil and CQ have a synergistic antitumor effect.
引用
收藏
页码:803 / 809
页数:7
相关论文
共 18 条
[1]  
AKAGI T, 1976, ACTA MED OKAYAMA, V30, P215
[2]   Molecular basis for the substrate specificity of protein kinase B; Comparison with MAPKAP kinase-1 and p70 S6 kinase [J].
Alessi, DR ;
Caudwell, FB ;
Andjelkovic, M ;
Hemmings, BA ;
Cohen, P .
FEBS LETTERS, 1996, 399 (03) :333-338
[3]   PIKKing on PKB: regulation of PKB activity by phosphorylation [J].
Bozulic, Lana ;
Hemmings, Brian A. .
CURRENT OPINION IN CELL BIOLOGY, 2009, 21 (02) :256-261
[4]   Naftopidil for the treatment of benign prostate hyperplasia: a systematic review [J].
Castiglione, Fabio ;
Benigni, Fabio ;
Briganti, Alberto ;
Salonia, Andrea ;
Villa, Luca ;
Nini, Alessandro ;
Di Trapani, Ettore ;
Capitanio, Umberto ;
Hedlund, Petter ;
Montorsi, Francesco .
CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (04) :719-732
[5]   Antitumor Action of α1-Adrenoceptor Blockers on Human Bladder, Prostate and Renal Cancer Cells [J].
Gotoh, Akinobu ;
Nagaya, Hisao ;
Kanno, Takeshi ;
Nishizaki, Tomoyuki .
PHARMACOLOGY, 2012, 90 (5-6) :242-246
[6]   Effect of α1-adrenoceptor antagonist exposure on prostate cancer incidence:: An observational cohort study [J].
Harris, Andrew M. ;
Warner, Bradley W. ;
Wilson, John M. ;
Becker, Aaron ;
Rowland, Randall G. ;
Conner, William ;
Lane, Matthew ;
Kimbler, Kimberly ;
Durbin, Eric B. ;
Baron, Andre T. ;
Kyprianou, Natasha .
JOURNAL OF UROLOGY, 2007, 178 (05) :2176-2180
[7]   Naftopidil, a Selective α1-Adrenoceptor Antagonist, Suppresses Human Prostate Tumor Growth by Altering Interactions between Tumor Cells and Stroma [J].
Hori, Yasuhide ;
Ishii, Kenichiro ;
Kanda, Hideki ;
Iwamoto, Yoichi ;
Nishikawa, Kohei ;
Soga, Norihito ;
Kise, Hideaki ;
Arima, Kiminobu ;
Sugimura, Yoshiki .
CANCER PREVENTION RESEARCH, 2011, 4 (01) :87-96
[8]   Inhibition of PI3K/Akt/mTOR Signaling by Natural Products [J].
Huang, Shile .
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2013, 13 (07) :967-970
[9]   Naftopidil, a selective α-1 adrenoceptor antagonist, inhibits growth of human prostate cancer cells by G1 cell cycle arrest [J].
Kanda, Hideki ;
Ishii, Kenichiro ;
Ogura, Yuji ;
Imamura, Tetsuya ;
Kanai, Masahiro ;
Arima, Kiminobu ;
Sugimura, Yoshiki .
INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (02) :444-451
[10]  
Martin FM, 2008, GENE THER MOL BIOL, V12B, P253